In other words, the drugs have to demonstrate a certain amount of weight loss, says Kushner
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes
however, this occurs through the PH domain and/or through interactions with the catalytic domain
What this can look like: observing hormone patterns across cycles identifying ovulation patterns over time comparing cycles before and during GLP-1 use noticing trends, not just single changes Important context: Tracking is observational , not diagnostic Hormonal changes can have multiple causes GLP-1 is one of several factors that may influence patterns The goal is not to explain why but to help you capture whats changing
(PubMed) Callaghan BC, Little AA, Feldman EL, Hughes RA
Yes, you can switch between GLP-1 medications